This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chusho, H. Articles by Nakao, K. Search for Related Content PubMed PubMed Citation Articles by Chusho, H. Articles by Nakao, K.

Genetic Models Reveal That Brain Natriuretic Peptide Can Signal through Different Tissue-Specific Receptor-Mediated Pathways¹

Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan; and Howard Hughes Medical Institute and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9050

Address all correspondence and requests for reprints to: Dr. Yoshihiro Ogawa, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. E-mail: ogawa{at}kuhp.kyoto-u.ac.jp

Brain natriuretic peptide (BNP), a hormone produced primarily by the cardiac ventricle, is thought to be involved in a variety of homeostatic processes through its cognate receptor, guanylyl cyclase A (GC-A). We previously created transgenic mice overexpressing BNP under the control of the liver-specific human serum amyloid P component promoter (BNP-transgenic mice) and demonstrated that they exhibit reduced blood pressure and cardiac weight accompanied by an elevation of plasma cGMP concentrations and marked skeletal overgrowth through the activation of endochondral ossification. To address whether BNP exerts its biological effects solely through GC-A, we produced BNP-transgenic mice lacking GC-A (BNP-Tg/GC-A^-/- mice) and examined their cardiovascular and skeletal phenotypes. The GC-A^-/- mice are hypertensive with cardiac hypertrophy relative to wild-type littermates, which is not alleviated by overexpression of BNP in BNP-Tg/GC-A^-/- mice. The BNP-Tg/GC-A^-/- mice, however, continue to exhibit marked longitudinal growth of vertebrae and long bones comparably to BNP-Tg mice. This study provides genetic evidence that BNP reduces blood pressure and cardiac weight through GC-A, whereas it dramatically alters endochondral ossification in the absence of this receptor. Therefore, the BNP-Tg/GC-A^-/- mice provide the first experimental model demonstrating that this natriuretic peptide can signal in a tissue-specific manner through a receptor other than GC-A.

This article has been cited by other articles:

				A. Marchini, B. Hacker, T. Marttila, V. Hesse, J. Emons, B. Weiss, M. Karperien, and G. Rappold BNP is a transcriptional target of the short stature homeobox gene SHOX Hum. Mol. Genet., December 15, 2007; 16(24): 3081 - 3087. [Abstract] [Full Text] [PDF]

				P. Moffatt, G. Thomas, K. Sellin, M.-C. Bessette, F. Lafreniere, O. Akhouayri, R. St-Arnaud, and C. Lanctot Osteocrin Is a Specific Ligand of the Natriuretic Peptide Clearance Receptor That Modulates Bone Growth J. Biol. Chem., December 14, 2007; 282(50): 36454 - 36462. [Abstract] [Full Text] [PDF]

				R. Kawakami, Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, Y. Nakagawa, M. Nakanishi, K. Tanimoto, S. Usami, et al. Overexpression of Brain Natriuretic Peptide Facilitates Neutrophil Infiltration and Cardiac Matrix Metalloproteinase-9 Expression After Acute Myocardial Infarction Circulation, November 23, 2004; 110(21): 3306 - 3312. [Abstract] [Full Text] [PDF]

				D. Muller, A. K. Mukhopadhyay, R. C. Speth, G. Guidone, R. Potthast, L. R. Potter, and R. Middendorff Spatiotemporal Regulation of the Two Atrial Natriuretic Peptide Receptors in Testis Endocrinology, March 1, 2004; 145(3): 1392 - 1401. [Abstract] [Full Text] [PDF]

				I. Boutin-Ganache, S. Picard, and C. F. Deschepper Distinct gene-sex interactions regulate adult rat cardiomyocyte width and length independently Physiol Genomics, December 26, 2002; 12(1): 61 - 67. [Abstract] [Full Text] [PDF]

				T. Miyazawa, Y. Ogawa, H. Chusho, A. Yasoda, N. Tamura, Y. Komatsu, A. Pfeifer, F. Hofmann, and K. Nakao Cyclic GMP-Dependent Protein Kinase II Plays a Critical Role in C-Type Natriuretic Peptide-Mediated Endochondral Ossification Endocrinology, September 1, 2002; 143(9): 3604 - 3610. [Abstract] [Full Text] [PDF]

				T. Suganami, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae, M. Kasahara, K. Yahata, H. Makino, Y. Fujinaga, Y. Ogawa, et al. Overexpression of Brain Natriuretic Peptide in Mice Ameliorates Immune-Mediated Renal Injury J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2652 - 2663. [Abstract] [Full Text] [PDF]

				I. Kishimoto, K. Rossi, and D. L. Garbers A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy PNAS, February 8, 2001; (2001) 51625598. [Abstract] [Full Text]

				W. K. Samson Editorial: The Power of Two--Molecular Differentiation of the Vascular and Bone Actions of the Natriuretic Peptides Endocrinology, October 1, 2000; 141(10): 3525 - 3526. [Full Text] [PDF]

				I. Kishimoto, K. Rossi, and D. L. Garbers A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy PNAS, February 27, 2001; 98(5): 2703 - 2706. [Abstract] [Full Text] [PDF]